What is Simethicone claims?
Simethicone allows gas bubbles in the stomach and intestines to come together more easily, which allows for easier passage of gas. It is used to relieve painful pressure caused by excess gas in the stomach and intestines. Simethicone is for use in babies, children, and adults.
Is Simethicone safe?
Although simethicone gas drops are sold over the counter, they should not be used in unlimited amounts. The recommended dose for children younger than age 2 is 20 mg. In most cases, this will be 0.3 mL, but check the product label to be sure. Carefully follow all dosing directions for gas drops and do not exceed the daily limit of doses. If you are unsure about how much to give your baby, talk with your doctor.
Does Simethicone work?
Most studies show no benefit for using gas drops to treat colic, according to a review of studies published in the January 2009 issue of “Clinical Pediatrics” and another published in February 2012 in the “Journal of Pediatrics and Child Health.” A few small studies have shown positive results, but they are the exception. Talk with your doctor before treating your newborn with gas drops. She may have other suggestions to help comfort your little one.
Natural solutions for your babies gas!
You don’t need to pump your kiddos with medicines. There are wonderful, natural ways to help her get rid of that pesky gas! Check out the Natural Gas Relief – how to help a gassy baby without medicines article for more information and to start helping your little one the natural way right now.
Simethicone in the treatment of infant colic: a randomized, placebo-controlled, multicenter trial.
To determine the efficacy of simethicone in the treatment of infant colic.
Randomized, double blind, placebo-controlled.
Three general pediatric practices in distinct geographic regions.
Eighty-three infants between 2 and 8 weeks of age with infant colic.
Treatment with simethicone and placebo in double blind crossover fashion.
A total of 166 treatment periods, ranging from 3 to 10 days, were evaluated in the 83 infants. Compared to baseline, improvement in symptoms was reported for 54% of the treatment periods, worsening was reported for 22%, and, for 24%, there was no change. The likelihood of the treatment period being rated as showing improvement, worsening, or no change was the same whether the infant was receiving placebo or simethicone. Twenty-eight percent of he infants responded only to simethicone, 37% only to placebo, and 20% responded to both. No statistically significant differences were noted among these three groups of responders. No difference could be shown even when infants with “gas-related symptoms” (by parental report) were separated out as a group.
Although both produced perceived improvements in symptoms, simethicone is no more effective than placebo in the treatment of infantile colic.